Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Biotech-IgG Equity AB (publ)
AB
Bankrupt
Org 5565296224
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 1996 · 30 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Biotech-IgG Equity AB (publ)
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
49M
36M
24M
12M
0M
2018: 24M
24M
2018
2019: 39M (+63% vs 2018)
39M
+63%
2019
2020: 20M (-49% vs 2019)
20M
-49%
2020
2021: 6M (-70% vs 2020)
6M
-70%
2021
2022: 12M (+100% vs 2021)
12M
+100%
2022
EBITDA
SEK millions
3M
1M
-2M
-4M
-6M
2018: -2M
-2M
2018
2019: -2M (0% vs 2018)
-2M
0%
2019
2020: -4M (-100% vs 2019)
-4M
-100%
2020
2021: -1M (+75% vs 2020)
-1M
+75%
2021
2022: 1M (+200% vs 2021)
1M
+200%
2022
Income statement
SEK thousands
Item
2022
2021
2020
2019
2018
Revenue
12 282
5 536
19 657
39 349
24 086
Staff expenses
—
—
—
—
—
EBITDA
956
−681
−3 554
−2 043
−1 993
Depreciation & amort.
−69
−69
−56
−56
−27
EBIT
887
−750
−3 610
−2 099
−2 020
Net financials
−86 725
2 996
−1 702
−2 380
−29 971
Profit before tax
−85 838
2 246
−4 512
−3 473
−16 988
Tax
−0
−0
−0
−19 334
19 334
Net profit
−85 838
2 246
−4 512
−22 807
2 346
Balance sheet
SEK thousands
Item
2022
2021
2020
2019
2018
Total assets
89 556
174 330
9 088
13 581
33 635
Equity
55 127
128 883
5 185
9 857
22 681
Long-term debt
3 706
0
1 150
1 637
1 150
Short-term debt
30 723
45 447
2 753
2 087
9 804
Total debt
34 429
45 447
3 903
3 724
10 954
Financial ratios
5-year trend
EBITDA margin
7,8 %
This company
15,8 %
Market median
This company
Market median
51% below market
2018
2022
Equity ratio
61,6 %
This company
38,2 %
Market median
This company
Market median
61% above market
2018
2022
Return on equity
−155,7 %
This company
18,4 %
Market median
This company
Market median
946% below market
2018
2022
Net profit margin
−698,9 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2018
2022
Asset turnover
0,14×
This company
1,12×
Market median
This company
Market median
88% below market
2018
2022
Debt / equity
0,62×
This company
0,62×
Market median
This company
Market median
0% above market
2018
2022
Annual reports & filings
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
More on Biotech-IgG Equity AB (publ)
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
